openPR Logo
Press release

Oncology Drugs Market Rapidly Develop New Product Like Hoffmann-La Roche AG, Novartis International AG, Celgene Corporation, Johnson & Johnson, Bristol-Myers Squibb, Pfizer Inc., Merck & Co., Eli Lilly and Company, AbbVie, Inc., AstraZeneca plc., Bayer AG

07-19-2019 07:21 AM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

Oncology Drugs

Oncology Drugs

High cost of cancer drugs and adoption of alternative treatment options such as surgery and radiation therapy are major factors hindering the oncology drugs market growth. Several blockbuster oncology drugs in the market are expected to lose patent during 2018-2020, which is turn acts as an opportunities for emerging players in the global oncology drugs market.

Cancer is one of the deadliest disease with less chance of survival as the disease progresses. International Agency for Research on Cancer published GLOBOCAN 2018 report, which estimates cancer incidence and mortality rate. This report focus on geographic variability of cancer incidence rate and mortality rate across 20 world regions. This report projected 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. Therefore, high prevalence of cancer is expected to be major factor for growth of the global oncology drugs market.

Free Request Sample of Report: www.coherentmarketinsights.com/insight/request-sample/2332

According to a report by Pharmaceutical Research and Manufacturers Association in 2015, over 800 drugs are in development stage targeting various types of cancer. Moreover, same source suggested that around 73% of personalized medicine under development are targeted towards cancer.

Melanoma, colorectal cancer, blood cancer, breast cancer, lung cancer, and prostate cancer are the most targeted cancer for drug development. According to International Federation of the Pharmaceutical Manufacturers Association’s report published in 2017, in 2014, the number of drugs in development for cancer was 1,919.

Increasing number of drugs are being approved for treating various types of cancer. According to U.S. FDA, around 16 new drugs were approved in 2017 for treatment of cancer. Moreover, by mid November 2018, eight more drugs were approved for cancer. Notable drug approvals from 2017 include,

Yescarta from Kite Pharmaceuticals that consist of the axicabtagene ciloleucel, for the treatment of relapsed or refractory large B-cell lymphomas (approved in October 2017)

Report with Discount Available @ https://www.coherentmarketinsights.com/insight/request-discount/2332

Detailed Segmentation:

Global Oncology Drugs Market, By Drug Type:
Cytotoxic Drugs
Alkylating Agents
Antimetabolites
Others
Targeted Drugs
Monoclonal Antibodies
Tyrosine Kinase Inhibitors
Others
Hormonal Drugs
Ovarian Function Blockers
Estrogen Production Blockers
Estrogen’s Effect Blockers
Selective Estrogen Receptor Modulators (SERMs)
Others
Global Oncology Drugs Market, By Cancer Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Blood Cancer
Bladder Cancer
Others
Global Oncology Drugs Market, By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

Purchase Copy of This Business Research Report: www.coherentmarketinsights.com/insight/buy-now/2332

Major players operating in the global oncology drugs market include, Hoffmann-La Roche AG, Novartis International AG, Celgene Corporation, Johnson & Johnson, Bristol-Myers Squibb, Pfizer Inc., Merck & Co., Eli Lilly and Company, AbbVie, Inc., AstraZeneca plc., Bayer AG, and Amgen Inc.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Drugs Market Rapidly Develop New Product Like Hoffmann-La Roche AG, Novartis International AG, Celgene Corporation, Johnson & Johnson, Bristol-Myers Squibb, Pfizer Inc., Merck & Co., Eli Lilly and Company, AbbVie, Inc., AstraZeneca plc., Bayer AG here

News-ID: 1807294 • Views:

More Releases from Coherent Market Insights (CMI)

Plastic Surgery Software Market Expands with AI Integration and Patient Visualization Tools| Coherent Market Insights
Plastic Surgery Software Market Expands with AI Integration and Patient Visualiz …
The plastic surgery software industry is witnessing transformative growth, driven by increased digital adoption and a rising demand for enhanced clinical outcomes and patient management solutions. The market's evolution focuses on providing integrated platforms to streamline appointment scheduling, patient records, and procedural planning. This dynamic shift embodies the changing landscape of surgical practices globally, showcasing significant potential for business growth. Market Size and Overview The Plastic Surgery Software market size is
Food And Beverage Robotic System Integration For Pick And Place Application Market to Grow at a CAGR of 10.91% by 2032 | Blueprint Automation, Bradman Lake Group, EPIC Systems Inc.
Food And Beverage Robotic System Integration For Pick And Place Application Mark …
Global Food And Beverage Robotic System Integration For Pick And Place Application Market Growing Demand and Growth Opportunity 2025-2032: The Coherent Market Insights A new report research on the Food And Beverage Robotic System Integration For Pick And Place Application Market Share from 2025 to 2032 provides accurate economic, global, and country-level predictions and analyses. It presents a comprehensive view of the competitive landscape, along with a detailed supply chain analysis
Pharmaceutical Drug Delivery Market Expected to Expand at a Steady 2024-2031 | Johnson and Johnson, Merck & Co, Inc., Bayer AG
Pharmaceutical Drug Delivery Market Expected to Expand at a Steady 2024-2031 | J …
The latest market intelligence report published by CMI with the title "Global Pharmaceutical Drug Delivery Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Pharmaceutical industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database. The Research report on Pharmaceutical Drug Delivery Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing
Huge Growth in Mobile Imaging Services Market 2023 to see Future Opportunities 2030 | Carestream Health, Accurate Imaging, Inc., Alliance HealthCare Services
Huge Growth in Mobile Imaging Services Market 2023 to see Future Opportunities 2 …
𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Mobile imaging services are provided by trained professionals who are equipped with state-of-the-art imaging technology that can be transported and set up on location. The images obtained through mobile imaging services are then transmitted electronically to the patient's healthcare provider for analysis and diagnosis. Mobile imaging services are used in a variety of healthcare settings, including hospitals, clinics, nursing homes, and home health agencies. They are particularly useful for imaging patients

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase